Results 1 to 10 of about 36,684 (227)

Hyperkalemia on ECG [PDF]

Journal of Education and Teaching in Emergency Medicine, 2016
History of present illness: A 34-year-old diabetic female presented to the emergency department with chest pain status-post AICD firing. She described the pain as a “12 out of 10” which woke her from sleep at 0200, one hour prior to arrival. Vitals were
Bryson Hicks
doaj   +2 more sources

Hyperkalemia - a review article [PDF]

Journal of Education, Health and Sport, 2019
Introduction: Potassium is critical cation in physiological functions. Hyperkalemia is a common electrolyte disorder, defined as potassium level above 5,5 mmol/L.
Marcin Makuch, Marcelina Makuch, Kamila Tuzim   +2 more
doaj   +4 more sources

Hyperkalemia: Prevalence, Predictors and Emerging Treatments

Cardiology and Therapy, 2022
It is well established that an elevated potassium level (hyperkalemia) is associated with a risk of adverse events including morbidity, mortality and healthcare system cost. Hyperkalemia is commonly encountered in many chronic conditions including kidney
Karthik K Tennankore, Jo-Anne Wilson, Keigan M More   +2 more
exaly   +2 more sources

Patterns and risk factors of hyperkalemia recurrence among heart failure patients [PDF]

Frontiers in Cardiovascular Medicine
BackgroundHyperkalemia, a life-threatening electrolyte condition, is linked to arrhythmias and sudden death, but evidence on its recurrence in heart failure (HF) patients is limited.MethodsWe conducted a cohort study using de-identified EHR data from ...
Christopher G. Rowan, Geraldine Francisco, Raymond C. Chang, K. Arnold Chan, Ravi Dhingra   +4 more
doaj   +2 more sources

Junctional Bradikardia pada Pasien Hiperkalemia

Jurnal Kesehatan Andalas, 2021
Hyperkalemia is a life-threatening electrolyte abnormality resulting in cardiac arrhythmia. Hyperkalemia may also cause bradycardia with junctional rhythm.
Cokorda Istri Padmi Suwari, Bayu Puradipa, Ni Luh Eka Sriayu Wulandari   +2 more
doaj   +1 more source

The Impact of Hyperkalemia on Mortality and Healthcare Resource Utilization Among Patients With Chronic Kidney Disease: A Matched Cohort Study in China

Frontiers in Public Health, 2022
ObjectivesThis study aimed to estimate the impact of hyperkalemia on 1-year survival and all-cause healthcare resource utilization among patients with chronic kidney disease in China.MethodsAdult new-onset chronic kidney disease patients were identified ...
Jiahui Zhang, Jiahui Zhang, Xiaoning He, Xiaoning He, Jing Wu, Jing Wu   +5 more
doaj   +1 more source

RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study

Frontiers in Cardiovascular Medicine, 2022
Hyperkalemia is common in patients treated with renin–angiotensin–aldosterone system inhibitors (RAASis), and it represents the main cause of the large gap reported between guideline recommendations and real-world practice in chronic kidney disease (CKD).
Eleonora Riccio, Ivana Capuano, Pasquale Buonanno, Michele Andreucci, Michele Provenzano, Maria Amicone, Manuela Rizzo, Antonio Pisani   +7 more
doaj   +1 more source

Prediction of hyperkalemia in ESRD patients by identification of multiple leads and multiple features on ECG

Renal Failure, 2023
Background Patients with end-stage renal disease (ESRD) especially those undergoing dialysis have a high prevalence of hyperkalemia, which must be detected and treated immediately.
Daojun Xu, Bin Zhou, Jiaqi Zhang, Chenyu Li, Chen Guan, Yuxuan Liu, Lin Li, Haina Li, Li Cui, Lingyu Xu, Hang Liu, Li Zhen, Yan Xu   +12 more
doaj   +1 more source

Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical OutcomesA Danish Population‐Based Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundData on the true burden of hyperkalemia in patients with heart failure (HF) in a real‐world setting are limited. Methods and ResultsIncidence rates of hyperkalemia (first blood test with a potassium level >5.0 mmol/L) in primary or hospital ...
Reimar Wernich Thomsen, Sia Kromann Nicolaisen, Pål Hasvold, Ricardo Garcia‐Sanchez, Lars Pedersen, Kasper Adelborg, Martin Egfjord, Kenneth Egstrup, Henrik Toft Sørensen   +8 more
doaj   +1 more source

Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study

National Journal of Physiology, Pharmacy and Pharmacology, 2020
Background: Angiotensin-converting enzyme (ACE) inhibitors are commonly used in clinical practice to treat hypertension. Hyperkalemia develops in approximately 10% of outpatients within a year of prescription of these drugs.
Vishnupriya Ramakrishnan, Suganeshwari Soundarapandian   +1 more
doaj   +1 more source